Penny Stocks To Follow Now – January 27th

30 Jan 2026, 13:22 by Kim Johansen · The Markets Daily

Nuwellis, TEN, Global Interactive Technologies, X3, and Vyome are the five Penny stocks to watch today, according to MarketBeat’s stock screener tool. Penny stocks are low-priced shares of small or microcap companies—often trading for under $5 per share (commonly under $1)—that frequently trade over-the-counter or on smaller exchanges. They tend to be highly speculative and illiquid, with wide bid–ask spreads and greater risk of price manipulation or total loss, so they are considered high-risk investments for most investors. These companies had the highest dollar trading volume of any Penny stocks within the last several days.

Nuwellis (NUWE)

Nuwellis, Inc., a medical device company, develops, manufactures, and commercializes medical devices used in ultrafiltration therapy. The company offers Aquadex FlexFlow and Aquadex SmartFlow systems, which are used to treat patients suffering from fluid overload due to heart failure. Its Aquadex FlexFlow system includes a console, disposable blood circuit set, and disposable catheter.

Read Our Latest Research Report on NUWE

TEN (XHLD)

We are a provider of event planning, production, and broadcasting services headquartered in Pennsylvania. We mainly produce virtual and hybrid events and physical events. Virtual and hybrid events involve virtual and hybrid event planning, production and broadcasting services, and continuing education services, all of which are supported by our proprietary Xyvid Pro Platform.

Read Our Latest Research Report on XHLD

Global Interactive Technologies (GITS)

Read Our Latest Research Report on GITS

X3 (XTKG)

X3 Holdings Co Ltd. provides technology solutions and services worldwide. The company offers Global Trade Platform, a digital platform for trading partners, service providers, and government authorities. It also engages in bitcoin cryptomining operations, renewable energy projects, and agriculture technologies and trading.

Read Our Latest Research Report on XTKG

Vyome (HIND)

ReShape Lifesciences Inc., a medical device company, provides products and services that manages and treat obesity and metabolic diseases in the United States, Australia, Europe, and internationally. The company’s product portfolio includes Lap-Band System, a minimally invasive long-term treatment of severe obesity and more invasive surgical stapling procedures, such as the gastric bypass or sleeve gastrectomy; and ReShape Vest system, an investigational, minimally invasive, laparoscopically implanted medical device that wraps around the stomach to enable weight loss in obese and morbidly obese patients without cutting or permanently removing portions of the stomach, or bypassing any portion of the gastrointestinal tract.